Gainers

• Can Fite Biopharma (AMEX:CANF) stock rose 7.1% to $1.66 during Wednesday's after-market session. The market value of their outstanding shares is at $3.5 million.
• iTonic Holdings (NASDAQ:ITOC) stock moved upwards by 5.88% to $2.31. The market value of their outstanding shares is at $14.7 million.
• NewGenIvf Group (NASDAQ:NIVF) stock increased by 5.65% to $0.31.
• bioAffinity Technologies (NASDAQ:BIAF) shares moved upwards by 4.7% to $2.54. The market value of their outstanding shares is at $1.4 million. As per the press release, Q3 earnings came out 3 days ago.
• enGene Therapeutics (NASDAQ:ENGN) stock moved upwards by 3.88% to $1.87. The company's market cap stands at $111.9 million.
• Orthofix Medical (NASDAQ:OFIX) stock rose 3.51% to $7.43. The market value of their outstanding shares is at $290.0 million. As per the press release, Q3 earnings came out 2 days ago.

Losers

• OptimizeRx (NASDAQ:OPRX) stock fell 12.6% to $7.82 during Wednesday's after-market session. The company's market cap stands at $172.9 million. The company's, Q3 earnings came out today.
• Picard Medical (AMEX:PMI) shares declined by 6.72% to $7.5. The company's market cap stands at $16.5 million.
• Accendra Health (NYSE:ACH) stock decreased by 5.24% to $0.14. The market value of their outstanding shares is at $11.5 million. As per the news, the Q3 earnings report came out 4 days ago.
• SILO Pharma (NASDAQ:SILO) shares fell 4.31% to $1.78. The market value of their outstanding shares is at $4.1 million.
• Beyond Air (NASDAQ:XAIR) shares decreased by 3.81% to $2.53. The company's market cap stands at $2.4 million. As per the news, the Q2 earnings report came out today.
• Co-Diagnostics (NASDAQ:CODX) stock fell 3.57% to $0.27. The market value of their outstanding shares is at $2.5 million. As per the press release, Q3 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.